Professor Richard M. Bergenstal
Co-Chair, Rising Stars Educational Program
Executive Director, International Diabetes Center
Clinical Professor, University of Minnesota
Richard M. Bergenstal, MD, is an endocrinologist and Executive Director of the International Diabetes Center at Park Nicollet. He is Clinical Professor in the Department of Medicine at the University of Minnesota and served as President, Science & Medicine of the American Diabetes Association in 2010. In 2007, Dr. Bergenstal was named the ADA’s Outstanding Physician Clinician of the Year and in 2010 he was awarded the Banting Medal for Service for outstanding leadership and service to the American Diabetes Association. Dr. Bergenstal received his MD and endocrine training from the University of Chicago where he was an Assistant Professor of Medicine before joining the International Diabetes Center in 1983. His clinical research has focused on glucose control and diabetes complications and he has served as a Principal Investigator of five NIH trials: the Diabetes Control and Complications Trial (DCCT) in type 1 diabetes and the Action to Control Cardiovascular Risks in Diabetes (ACCORD) study and the Glycemic Reduction Approaches in Diabetes: A Comparative Effectiveness Study (GRADE) study in type 2 diabetes and 2 technology focused NIH grants (Hygieia – study of insulin dose advisor system, Artificial Pancreas grant to study next generation automated insulin delivery systems).
Dr. Bergenstal’s clinical efforts have been directed toward improving systems of care for patients with diabetes by translating new research findings into practice. He studies the effective utilization of insulin therapy and standardization glucose monitoring (SMBG and CGM) to improve glucose control and clinical outcomes. He teaches nationally and internationally on the importance of patient-centered team care, has been listed in Best Doctors in America since it began in 1992, has published over 250 peer reviewed scientific articles in diabetes.
George L. Bakris, MD, MA, Hon. DSc, F.A.S.H, F.A.S.N., F.A.H.A.
Professor of Medicine (tenured)
Director, ASH Comprehensive Hypertension Center The University of Chicago Medicine, Chicago, IL
Dr. Bakris is a tenured Professor of Medicine and Director of the ASH Comprehensive Hypertension Center in the Department of Medicine at the University of Chicago Medicine.
Dr. Bakris has published over 800 peer-reviewed articles and book chapters in the areas of diabetic kidney disease, hypertension and progression of nephropathy. He is the Editor or Co-Editor of 20 books, in the areas of Kidney Disease Progression and Diabetes as well as the new 3rd edition of Hypertension: A Companion to Braunwald’s The Heart. Additionally, he is an Associate Editor of the International Textbook of Cardiology. He was a member of the NIH National High Blood Pressure Education Program Working Group on Hypertension and Renal Disease (1994). He also served as a special government expert to the Cardio-renal Advisory Board of the FDA and to CMS (1994-2008). He was a co-principal investigator on the NIH Clinical Research training grant for clinical research (K30) (1999-2004). He chaired the first National Kidney Foundation Consensus report on blood pressure and impact on renal disease progression (2000). He has also served on many national guideline committees including: The Joint National Committee Writing Groups VI & 7 (1997, 2003), the JNC 7 executive committee (2003), the American Diabetes Association Clinical Practice Guideline Committee (2002-2004), the National Kidney Foundation (K-DOQI) Blood Pressure Guideline committee (2002-2004 & 2013), (K-DOQI) Diabetes Guideline committee (2003- 2005 & 2014), Chair, ADA BP Consensus Report (2016) and writing committee ACC/AHA Resistant Hypertension Consensus report (2016-2017). Dr. Bakris is the past-president of the American College of Clinical Pharmacology (2000-2002) and the American Society of Hypertension (ASH). He is the current Editor-in-Chief, Am J Nephrology, Editor-in-Chief- Up-to-Date, Nephrology section, Hypertension Section Editor Up-to-Date and Assoc. Ed of Diabetes Care. He serves on more than 18 editorial boards including Nephrology, Dialysis & Transplant, Hypertension, J Hypertension and J American Soc. Hypertension. Additionally, he is the Hypertension editor of the Merck Manuel.
Anders L. Carlson, MD
International Diabetes Center at Park Nicollet
HealthPartners Specialty Center, St. Paul, MN
Anders L. Carlson, MD, is a Medical Director with the International Diabetes Center at Park Nicollet in St. Louis Park, MN, and an endocrinologist at HealthPartners and Regions Hospital in St. Paul, MN. He also serves as the Director of the Diabetes Program for HealthPartners. He is an assistant professor of the University of Minnesota Medical School. He is a member of the American Diabetes Association, Endocrine Society and American Association of Clinical Endocrinologists.
Dr. Carlson received his MD from the University of Minnesota Medical School. He completed his internal medicine residency at Hennepin County Medical Center in Minneapolis. He trained in endocrinology and diabetes at the University of Vermont in Burlington, VT. While a fellow he worked in Dr. John Leahy’s laboratory, where his research focused on insulin signal regulation within the beta cell, and the role of incretins in insulin regulation. His current research efforts are centered on diabetes technology, prevention and education.
Amy Criego, MD, MS
Pediatric Endocrinologist - Park Nicollet Clinic
Medical Director - International Diabetes Center
Amy Criego MD, MS is Department Chair in Pediatric Endocrinology at Park Nicollet Clinic and is a Medical Director at the International Diabetes Center (IDC). She attended undergraduate and medical school at the University of North Dakota. She underwent residency training in Pediatrics at DeVos Children’s Hospital in Grand Rapids, MI and completed her fellowship training in Pediatric Endocrinology at the University of Minnesota in 2005.
Dr. Criego is primary investigator for the Type 1 Diabetes Exchange. She is a primary investigator and sub-investigator in medical device studies and new therapies for diabetes management at the IDC. She has been involved with the collaboration between the International Diabetes Center and Melrose Institute helping to improve care for patients with eating disorders and diabetes. She also provides clinic care to children, adolescents and young adults with diabetes and other endocrine disorders
Dr. Criego is active in the American Diabetes Association having participated in the Scientific Sessions Planning Committee for 2012 and 2013 and serves as Medical Director for Camp Daypoint/Camp Needlepoint which is an America Diabetes Sponsored camp for children and adolescents with type 1 diabetes.
George Grunberger, MD, FACP, FACE
Dr. Grunberger is the chairman of Grunberger Diabetes Institute (GDI) in Bloomfield Hills, Michigan. He is Clinical Professor of Internal Medicine and of Molecular Medicine & Genetics at Wayne State University School of Medicine, Professor of Internal Medicine at Oakland University William Beaumont School of Medicine and Visiting Professor at First Faculty of Medicine at Charles University in Prague (Czech Republic).
Dr. Grunberger established and directed the Diabetes Program at the Detroit Medical Center (1986-2002) and was the Medical Director of Wayne State University’s Comprehensive Diabetes Center. He was tenured Full Professor of Internal Medicine and Molecular Medicine and Genetics since 1986. Between 1997 and 2001 he directed the Center for Molecular Medicine and Genetics. He served as interim Chairman of the Department of Internal Medicine and Physician-in-Chief of the Detroit Medical Center (1995-1996). Dr. Grunberger did his fellowship and then research work at the Diabetes Branch of NIDDK/NIH, internal medicine training at Case Western Reserve University in Cleveland, M.D. training at the New York University School of Medicine and received bachelor’s degree at Columbia College of Columbia University.
Dr. Grunberger has published over 150 peer-reviewed manuscripts in addition to review articles, abstracts and book chapters. His research interests cover the spectrum of subjects related to diabetes and its complications.
Dr. Grunberger has been an active member of professional organizations. He is Past President of American Association of Clinical Endocrinologists. He is a co-editor of two international diabetes journals. Dr. Grunberger has served as an educator of medical students, residents, endocrinology fellows, master’s and Ph.D. candidates, and junior faculty over the past 35 years.
Professor David Owens, CBE, MD, FRCP, FIBIOL
Emeritus Professor of Diabetes Medicine, Swansea University
Cardiff University School of Medicine, Wales, United Kingdom
Professor Owens has been involved in the management of diabetes and related research activities for more than 35 years. His primary interests include the evolution of glucose intolerance and pathophysiology of type 2 diabetes including new and emerging therapies. He also has a keen interest in all micro‐vascular complications of diabetes especially diabetic retinopathy and nephropathy and introduced the first community wide National Diabetic Retinopathy Screening Service for Wales as its Director and Clinical Lead from its establishment in 2002 up to 2007. With his interest in research activities, he was proud to have been the inaugural Chairperson for the Diabetes Research Network in Wales in 2005. He continues to support research activities in the area of diabetic retinopathy and the natural history of diabetes and has supervised many MD, PhD and MSc students over the years.
His commitment to education led to the development of the Post Graduate Diploma course in Diabetes launched over 3 years ago and he continues to encourage health professionals from all over the world to continue their education in this field. Professor Owens has published over 300 peer‐reviewed papers, in addition to reviews and book chapters. His early work regarding insulin was published as a single author book on Human Insulin in 1986 based on his research on the pharmacokinetic and pharmacodynamic characteristics of subcutaneously administered insulins. Professor Owens is a member of the Association of Physicians of Great Britain and Ireland and is a Fellow of the Royal College of Physicians and Institute of Biology. His opinion has been sought by numerous diabetes‐related advisory boards for both UK and International governmental organizations. In 2002 Professor Owens was awarded the CBE for his services to diabetes and the National Health Service. In 2018 Professor Owens was awarded the Excellence in Patient Care International Award from the Royal College of Physicians, London, UK.
Rodica Pop-Busui, MD, PhD
Professor of Internal Medicine, Metabolism, Endocrinology and Diabetes
Associate Chair of Clinical Research, Department of Internal Medicine
Co-Director, Neuropathy Center, University of Michigan, Ann Arbor, MI, USA
Rodica Pop-Busui, MD, PhD, is a prominent diabetologist at Michigan Medicine and a recognized leader in the field of diabetes and diabetes complications. She is the Associate Chair for Clinical Research in the Department of Internal Medicine. Her research interests involve the chronic complications of diabetes, diabetic peripheral and cardiovascular autonomic neuropathy, nephropathy and cardiovascular disease, and novel technologies for treating type 1 diabetes.
Dr. Pop-Busui has published over 150 peer-reviewed manuscripts and book chapters, and received awards from the Fulbright Foundation, the American Diabetes Association (ADA), and the University of Michigan. She has been an elected member of the Clinical Practice Committee of the ADA, and most recently was elected as the Chair of the ADA Scientific Research Review, and of Research Committee of the landmark DCCT/EDIC study.
She has contributed her research efforts and leadership to some of the most important national and international diabetes clinical trials to date including: the NHLBI-funded Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial, the following NIDDK-funded trials: Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications, A Multicenter Clinical Trial of Allopurinol to Prevent GFR Loss in Type 1 Diabetes (“PERL), “Glycemia Reduction Approaches for Diabetes: A Comparative Effectiveness Study (GRADE), Bypass Angioplasty Revascularization Diabetes 2 (BARI- 2D), Targeting Inflammation with Salsalate for Type 2 Diabetes (TINSAL T2D), and many others funded by Pharma such as the Cardiovascular Safety of Insulin Degludec versus Insulin Glargine in Patients with Type 2 Diabetes at High Risk of Cardiovascular Events (DEVOTE).
Nico Pronk, Ph.D., M.A., FACSM, FAWHP
Dr. Nico Pronk is President of the HealthPartners Institute and Chief Science Officer at HealthPartners, Inc. and holds a faculty appointment as Adjunct Professor of Social and Behavioral Sciences at the Harvard T.H. Chan School of Public Health in Boston, Massachusetts.
Dr. Pronk’s work is focused on connecting evidence of effectiveness with practical applications of programs and practices, policies and systems that measurably improve population health and well-being. His work applies to the workplace, the care delivery setting, and the community and involves development of new models to improve health and well-being at the research, practice and policy levels.
Dr. Pronk was confirmed by the White House to serve as co-chair of the U.S. Secretary of Health and Human Services’ Advisory Committee on National Health Promotion and Disease Prevention Objectives for the year 2030 (aka “Healthy People 2030”). He is a current member of the Food and Nutrition Board at the National Academies of Sciences, Engineering and Medicine and is the founding and past president of the International Association for Worksite Health Promotion.
He is widely published in both the scientific and practice literatures with more than 400 articles, books, and book chapters and is an international speaker on population health and well-being. Dr. Pronk received his doctorate degree in exercise physiology at Texas A&M University and completed his post-doctoral studies in behavioral medicine at the University of Pittsburgh Medical Center at the Western Psychiatric Institute and Clinic in Pittsburgh, Pennsylvania.
HealthPartners Institute is one of the largest medical research and education centers in the Midwest, the Institute has about 450 studies underway each year, trains more than 500 medical residents and fellows and more than 500 students, and provides continuing medical education for 25,000 clinicians as well as patient education and clinical quality improvement. HealthPartners, founded in 1957 as a cooperative, is an integrated, non-profit, member-governed health system providing health care services and health plan financing and administration. It's the largest consumer governed nonprofit health care organization in the United States.
Gregg D. Simonson, PhD
Director, Professional Training and Consulting
International Diabetes Center;
Assistant Professor, University of Minnesota Medical School
Gregg D. Simonson, PhD, is currently the Director, Professional Training and Consulting at International Diabetes Center. He also holds an academic appointment as an Adjunct Assistant Professor in the Department of Family Practice and Community Health at the University of Minnesota Medical School.
Dr. Simonson earned his doctorate in molecular cell biology and biochemistry at the University of Minnesota. He held a post-doctoral research position at the University of Wisconsin Children’s Diabetes Center and was awarded a Juvenile Diabetes Foundation Post-Doctoral Fellowship for his research on diabetes gene therapy. Dr. Simonson currently oversees professional training and consulting at International Diabetes Center and is responsible for the development and delivery of continuing medical education programs for more than 1,000 health professionals annually to broaden their knowledge and practice of optimal management of diabetes. In addition, he oversees IDC Publishing, which offers educational resources for individuals with diabetes and the health professionals who serve them. His research interests include translation of evidence-based medicine into clinical practice through creation of algorithms and practice guidelines.
Dr. Simonson is a member of the American Diabetes Association (ADA) and Minnesota Department of Health Diabetes Steering Committee, having served as chair. He was the recipient of the 2015 Bruce Zimmerman Diabetes Award by the Minnesota Department of Health for leadership in promoting diabetes care, education and prevention. He has authored many original articles published in peer-reviewed journals and has presented abstracts of his research at numerous national and international scientific meetings. Dr. Simonson is a coauthor of Staged Diabetes Management (SDM), an evidence-based systematic approach for detecting and treating diabetes and its complications and numerous IDC patient education materials. He leads IDC Consulting Team and is actively involved in guiding healthcare organizations on diabetes quality improvement. He is also the lead trainer/facilitator of SDM program implementation in tribal communities, federally qualified health agencies, medical groups and integrated health care systems nationally and internationally.
Bernard Zinman CM, MD, FRCPC, FACP
Bernard Zinman is Professor of Medicine at the University of Toronto and Senior Scientist at the Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital. Dr. Zinman completed his medical degree at McGill University, where he also received his postgraduate training in internal medicine. He undertook further training at the University of Toronto in Endocrinology.
Dr. Zinman has authored more than 550 publications in national and international journals. He is the recipient of numerous awards including the Charles H. Best Medal for Distinguished Service in the Cause of Diabetes (awarded to the DCCT Investigators), the Alois Beringer Lecture Award, the Frederick G. Banting Award and the Gerald S. Wong Service Award of the Canadian Diabetes Association (CDA). In 2006 Dr. Zinman received the American Diabetes Association’s Outstanding Physician Clinician Award. In 2009, Dr. Zinman was awarded the Lifetime Achievement Award from the Canadian Diabetes Association and the Novartis Prize in Diabetes. and in 2010. In November 2011, Dr. Zinman was appointed to the Order of Canada, in recognition of his achievements in diabetes patient care and research. In May 2012, Dr. Zinman received the Diamond Jubilee Medal from Queen Elizabeth II. Most recently, for the past two years, Thompson Reuters ranked Dr. Zinman as among the top 1% of researchers cited in their specific field.
His main research interests include the long-term complications of diabetes mellitus, the development of new therapies for Type 1 and Type 2 diabetes, diabetes in Aboriginal communities, and studies directed at the prevention of diabetes.